Abstract:Objectives: Primary Sjögren's syndrome (pSS) is an autoimmune exocrinopathy classically presenting with sicca symptoms. Nonetheless, disease onset with extraglandular manifestations, including interstitial lung disease (ILD), is increasingly reported. However, studies investigating pSS patients presenting with ILD (pSS-ILD) are limited.Aim of this study was to better characterise the phenotype of pSS patients presenting with ILD in comparison to pSS patients with classicsicca-onset. We especially investigated whether the two groups differed in glandular involvement comparing functional, imaging andhistologic findings, as well as patient reported outcome (PRO). Methods: Consecutive newly diagnosed pSS patients, all fulfilling the ACR/EULAR 2016 criteria, were included in this cross-sectional study from September 2016 to October 2021. Presence of ILD at pSS diagnosis was defined based on clinical findings, imaging assessment and pulmonary function tests (PFT). In addition to functional tests, a minor salivary gland biopsy was performed in all cases, recording number of foci, focus score (FS) and GC-like structures. Salivary glands ultrasonography (SGUS) was graded using the OMERACT semiquantitative scoring system (0-3) based on parenchyma inhomogeneity. PRO including ESSPRI, OHIP and OSSDI were collected.Extraglandular clinical features and biological abnormalities included in the ESSDAI were recorded. Data were expressed as mean±SD for continuous variables and as absolute frequencies and percentages for categorical variables. Chi-Square test and Mann-Whitney U-test and ANOVA were performed for comparisons of categorical variables and continuous variables, respectively. Results: We included 178 newly diagnosed pSS patients (F:M=158:20). ILD was the first pSS manifestation in 11 (6%) cases, 8 F and 3 M, with a median time from ILD onset to pSS diagnosis of 2 years (25-75 IQ 1-4.5). Of the 11 pSS-ILD patients, HRCT pattern was defined as NSIP in 4, UIP in 4, NSIP+OP in 2 and LIP in 1 patient. Dyspnoea on exertion or chronic cough were reported by 7/11 (63.6%) patients.In comparison to sicca-onset patients, pSS-ILD patients presented an older age at diagnosis (55±13 vs. 70±7, p= 0.001) and a higher ESSDAI (3.9±4.7 vs. 12.3±4.3, p=0.001), driven by the pulmonary domain. Regarding glandular involvement, pSS-ILD patients reported milder xeropthalmia (VAS 5.8±3.1 vs. 2.8±3.5, p=0.002) and significative lower scores in OSDI (35.6±24.9 vs. 15.3±22.9, p=0.04) and OHIP (4.8±4.4 vs. 1.4±3.8, p=0.04), despite no significant differences observed between the two groups in ocular tests and unstimulated salivary flow rate. With respect to histology, no significant differences were found in number of foci, FS and GC-like structures. We observed a significantly different distribution of the SGUS OMERACT score in the two groups: none of pSS-ILD patients presented a SGUS OMERACT score ≥2 in the submandibular glands (SG), in contrast to 41/132 (31.1%) of the patients in the classical sicca-onset group (p=0.03). Finally, no significant differences were observed between the two groups with respect to non-pulmonary extraglandular manifestations, serologic features and other biological parameters. Conclusions: ILD-onset pSS patients represent an atypical phenotypic subset, with less pronounced sialadenitis structural changes in salivary glands, and with sicca symptoms probably overshadowed by the respiratory disease.

IgG and plasma viscosity as markers of disease activity in primary Sjogrens syndrome-related lymphocytic interstitial pneumonia

OP0185 Characteristics of Primary Sjögren's Syndrome Patients with IGG4-Positive Plasma Cells in Labial Salivary Glands

Characteristics of Primary Sjögren’s Syndrome Patients with IgG4 Positive Plasma Cells Infiltration in the Labial Salivary Glands

Lymphocytic interstitial pneumonia as a manifestation of SLE and secondary Sjogren's syndrome

Serum immunogiobulin A and its clinical role in primary Sjogren's syndrome

Clinical analysis of primary Sjogren's syndrome with interstitial lung disease

Serum biomarker-based risk model construction for primary Sjögren's syndrome with interstitial lung disease

Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study

Clinical features and risk factors for primary Sjögren’s syndrome combined with interstitial lung disease: a retrospective study

Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study

Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology

Sjogren's Syndrome and Pulmonary Disease

Identification of inflammatory markers as indicators for disease progression in primary Sjögren syndrome

Pulmonary Manifestations of Sjögren's Disease

Pulmonary involvement in primary Sjögren's syndrome

Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis

Interstitial Lung Disease In Non-Sicca Onset Primary Sjogren'S Syndrome: A Large-Scale Case-Control Study

Distinctive profile of monomeric and polymeric anti-SSA/Ro52 immunoglobulin A1 isoforms in saliva of patients with primary Sjögrens syndrome and Sicca

Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren's Syndrome

Clinical features of newly-diagnosed primary Sj(o)gren's syndrome: analysis of 86 cases

Clinical features of interstitial lung disease in primary Sj(o)gren's syndrome